UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?

Joubert, R; Mariot, V; Charpentier, M; Concordet, JP; Dumonceaux, J; (2020) Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD? Journal of Personalized Medicine , 11 (1) , Article 7. 10.3390/jpm11010007. Green open access

[thumbnail of jpm-11-00007.pdf]
Preview
Text
jpm-11-00007.pdf - Published Version

Download (2MB) | Preview

Abstract

Facioscapulohumeral dystrophy (FSHD, OMIM: 158900, 158901) is the most common dystrophy in adults and so far, there is no treatment. Different loci of the disease have been characterized and they all lead to the aberrant expression of the DUX4 protein, which impairs the function of the muscle, ultimately leading to cell death. Here, we used gene editing to try to permanently shut down DUX4 expression by targeting its poly(A) sequence. We used transcription activator-like effector nucleases (TALEN) and CRISPR-Cas9 nucleases in vitro on FSHD myoblasts. More than 150 TOPO clones were sequenced and only indels were observed in 4%. Importantly, in 2 of them, the DUX4 poly(A) signal was eliminated at the genomic level but DUX4 mRNA was still produced thanks to the use of a non-canonical upstream poly(A) signal sequence. These experiments show that targeting DUX4 PAS at the genomic level might not be an appropriate gene editing strategy for FSHD therapy.

Type: Article
Title: Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/jpm11010007
Publisher version: http://dx.doi.org/10.3390/jpm11010007
Language: English
Additional information: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Keywords: CRISPR-Cas9, D4Z4, DUX4, FSHD, TALEN, facioscapulohumeral dystrophy, gene editing, muscle, polyadenylation
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10118510
Downloads since deposit
59Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item